Ionis Pharmaceuticals Inc
IONS· Nasdaq
Released Oct 29, 2025, before the open
10-Q filed Oct 29, 2025, 29 days after period end · 0000874015-25-000266
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $156.72M | $133.81M | $144.21M | $159.77M |
| Net Income | -$128.61M | -$140.48M | -$147.41M | -$46.99M |
| EPS Diluted |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.80 |
| -$0.95 |
| -$1.03 |
| -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.